Le Lézard
Classified in: Health, Business
Subject: FNC

Enable Dental Raises Series A Financing to Expand Its Portable Dental Model


AUSTIN, Texas, Jan. 21, 2020 /PRNewswire-PRWeb/ -- Enable Dental announced the closing of its Series A financing in December, led by FCA Venture Partners, to scale its proprietary portable dental solution model. The uniquely developed solution leverages technological advancements in equipment and systems to serve in-need populations including geriatric, special needs, and people who are not well served by a traditional brick and mortar dental office. Enable's on-premise services have been delivered at independent and assisted living facilities, skilled nursing homes, substance abuse centers, group homes, healthcare institutions, hospitals, and personal residences.

Enable Dental provides the convenience of bringing clinicians on-demand to the patient. Many patients depend on a family member, caretaker, or facility to coordinate routine dental care. This coordination can be difficult and costly for patients and their caregivers, and Enable Dental has developed a uniquely scalable model to address these needs.

"At Enable Dental, we're focused on reducing barriers to dental care by putting the patient's needs first, integrating and coordinating between the medical and dental worlds to improve care, and utilizing technology and teledentistry where possible," said Ben Tiggelaar, President of Enable Dental.

The investment will be used to expand the platform into other high-demand geographies, develop technology systems, and build out its team of dedicated clinical partners. "As a clinician, I have seen firsthand the lack of access to care in our special needs and aging population. I strongly believe that Enable Dental's portable model can provide quality dental care to those that have been under-served by the traditional dental model. We improve the patient's quality of life by bringing care directly to those that need it the most and those left with few to no alternatives," said Dr. Andrew Nguyen, DDS, Clinical Director of Enable Dental.

The dental industry has been largely focused on consolidation and improving brick and mortar practices. "We believe the future of dentistry will be driven by alternative delivery models to lower the cost of delivery and provide access to more people," said Paul Langley, CEO of Enable Dental. "We are excited to accelerate our growth to bring convenient, quality care to more people in more places."

"Millions of people find it difficult or impossible to get needed dental care from brick and mortar practices. Enable Dental's unique model provides patients, families, and caregivers with high quality care in the convenience of their home," said Matthew A. King, Managing Partner of FCA Venture Partners, which led the investment round. "We are very pleased to partner with an innovative leader using technology to bring dental services to more people."

About Enable Dental:
Enable Dental currently supports portable on-premise dental operations in Texas, Kansas, Missouri, Colorado, and California and is a pioneering dental support organization (DSO). Enable Dental is re-imagining how dental care is delivered to individuals and organizations with unique needs. Visit http://www.enabledental.com/ for more information.

About FCA Venture Partners:
Founded in 1996, FCA Venture Partners has a long history of investing in successful healthcare entrepreneurs. The firm is passionate about building sustainable businesses and providing strategic value to their portfolio companies. FCA invests $3-6M in fast growing healthcare technology and services companies making processes in the industry faster, better, and cheaper while improving the quality of care and the patient experience. Located in Nashville and deeply involved in the growth of the U.S. healthcare community, FCA Venture Partners is poised to take advantage of disruptive opportunities that help move healthcare forward. For more information, visit https://www.fcavp.com.

 

SOURCE Enable Dental


These press releases may also interest you

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...

26 avr 2024
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: